Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Clinical trial NCT06705686 · RECRUITING

Trial details

NCT number: NCT06705686
Sponsor: TechnoGenesys, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-resistant Prostate Carcinoma

Start date: 2026-03-13
Primary completion: 2027-12-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.